Global Remdesivir Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Remdesivir Market Research Report 2024
It is a nucleoside analog with antiviral activity, with an EC50 value of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and an EC50 value of 30 for murine hepatitis virus in delayed brain tumor cells nM.
According to Mr Accuracy reports’s new survey, global Remdesivir market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Remdesivir market research.
Key manufacturers engaged in the Remdesivir industry include Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma and Hunan Warrant Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Remdesivir were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Remdesivir market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Remdesivir market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Gilead Sciences
Bright Gene
Hainan Haiyao
Kelun Pharma
Hunan Warrant Pharmaceutical
Segment by Type
10 mM*1 mL in DMSO
5mg
10mg
50mg
100mg
Hospital
Clinics
Drug Store
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Remdesivir report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Remdesivir market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Remdesivir market research.
Key manufacturers engaged in the Remdesivir industry include Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma and Hunan Warrant Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Remdesivir were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Remdesivir market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Remdesivir market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Gilead Sciences
Bright Gene
Hainan Haiyao
Kelun Pharma
Hunan Warrant Pharmaceutical
Segment by Type
10 mM*1 mL in DMSO
5mg
10mg
50mg
100mg
Segment by Application
Hospital
Clinics
Drug Store
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Remdesivir report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source